论文部分内容阅读
为了实现“消灭”淋巴丝虫病的承诺,印度卫生部最近制订了使用单剂海群生(DEC)和伊维菌素以明显改进丝虫病控制的计划。该国班氏丝虫病病例占全世界病例的38％,而马来丝虫病病例占30％。 1995年12月,以K.K.Datta博士为首的专家组和TDR/CTD丝虫病处主任G.P.Ramachandran参与制订了“印度丝虫病控制修正策略”草案,要求在今年的5月之前提供2亿片50mg的DEC,在新设立的全国丝
In order to realize its commitment to “eradicate lymphatic filariasis,” the Indian Ministry of Health has recently devised plans to significantly reduce filariasis using single-dose sea lions (DEC) and ivermectin. The country’s family of filariasis cases account for 38% of the world’s cases, while the case of malayi filariasis accounts for 30%. In December 1995, GPRamachandran, headed by Dr. KKDatta and GPRamachandran, Director of the TDR / CTD Filariasis Division, participated in the drafting of a draft “Modification Strategy for Filariasis Control in India” and requested that 200 million tablets of 50 mg DEC, the newly established national silk